GlobalFoundries to Invest $16 Billion to Expand Semiconductor Manufacturing in US; Shares Up Pre-Bell-February 2024-www.financetom.com

GlobalFoundries to Invest $16 Billion to Expand Semiconductor Manufacturing in US; Shares Up Pre-Bell

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GlobalFoundries to Invest $16 Billion to Expand Semiconductor Manufacturing in US; Shares Up Pre-Bell

Jun 4, 2025 5:53 AM

08:40 AM EDT, 06/04/2025 (MT Newswires) -- GlobalFoundries ( GFS ) said Wednesday it plans to invest $16 billion to further develop its semiconductor manufacturing and advanced packaging capabilities in its New York and Vermont facilities.

Shares were 1% higher in recent premarket activity.

Previous page： DocGo's Cardiac RMS Unit Signs Contract With Mississippi Hospital System Next page： Crown Holdings to Receive $300 Million From Eviosys Stake Sale

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

DocGo's Cardiac RMS Unit Signs Contract With Mississippi Hospital System

Dec 4, 2024

09:48 AM EST, 12/04/2024 (MT Newswires) -- DocGo ( DCGO ) said Wednesday that its Cardiac RMS subsidiary has signed a contract with an unnamed hospital system in Mississippi. Under the deal, DocGo's ( DCGO ) Cardiac RMS is scheduled to begin remote monitoring for nearly 3,000 patients with cardiac implantable electronic devices in early 2025. Financial terms were not...

Crown Holdings to Receive $300 Million From Eviosys Stake Sale

Dec 4, 2024

09:41 AM EST, 12/04/2024 (MT Newswires) -- Crown Holdings ( CCK ) said Wednesday it expects to receive about $300 million in net cash proceeds from the sale of its remaining 20% stake in Eviosys to Sonoco Products ( SON ) . Sonoco earlier said it had completed the acquisition of Eviosys from KPS Capital Partners. Crown's Chief Financial Officer...

Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?

Dec 4, 2024

On Wednesday, Eli Lilly And Co ( LLY ) revealed topline data from the SURMOUNT-5 phase 3b trial evaluating the efficacy and safety of Zepbound (tirzepatide) compared with Novo Nordisk A/S’ Wegovy (semaglutide) in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes. Zepbound provided a 47%...

Super Micro Computer Unusual Options Activity For December 04

Dec 4, 2024

Investors with a lot of money to spend have taken a bullish stance on Super Micro Computer ( SMCI ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something...